Dublin, Feb. 27, 2018 -- The "Epiomic Epidemioloy Series: Refractive Errors Forecast in 18 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.
The main role of the optical components of the eye is focusing rays of light on the retina. The situation in which parallel rays are focused properly is known as emmetropia. Various defects caused by the inability of the eye to converge the refracted rays on the retina are known as refractive errors (ametropias).
This report covers the features and epidemiology facts of hyperopia, myopia and presbyopia. The report provides the current prevalent population for refractive errors across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.
In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the author's analysis team, several features of refractive errors patients, as well as the main comorbidities of the covered conditions have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of refractive errors include:
- Eye strain
- Headaches
- Glaucoma
- Cataracts
- Amblyopia
- Anisometropia
- Diabetes mellitus
- Arterial hypertension
Key Topics Covered:
- Introduction
- Cause Of The Disease
- Risk Factors & Prevention
- Diagnosis Of The Disease
- Variation By Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With The Disease
- Methodology For Quantification Of Patient Numbers
- Top-Line Prevalence For Refractive Errors
- Hyperopia
- Myopia
- Presbyopia
- Features Of Refractive Error Patients
- Hyperopia
- Myopia
- Presbyobia
- Abbreviations Used In The Report
- Other Services & Solutions
- Reports & Publications
- Online Epidemiology Databases
- Online Pharmaceutical Pricing Database
- References
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/lsb4jw/refractive_errors?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900


Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



